Matching slides 303,780
Current window 207,571-207,600
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

207,571-207,600 of 303,780

filter-aware
03
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
05
The central diagram represents a knowledge graph or network of interconnected biological data points.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a process flow diagram to explain the platform's methodology.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
07
The slide features a screenshot of a software platform with a zoomed-in callout box showing a data table of mechanisms related to ALS.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
08
The slide shows a UI screenshot of a 'BenevolentAI' platform. It highlights a 'PPI Edge Details' modal window.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
09
The central diagram acts as a template for hypothesis generation: 'Can we treat [Target] by [Sign] [Mechanism] in [Cell type] by [Sign] [Mechanism]?'BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
10
The diagram shows a process flow from data inputs to model processing to target identification.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
12
The slide highlights a 'Triage criteria' panel with sliders for Biological Rationale, Ligandability, Safety, Tissue Expression, and Therapeutic Evidence.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
13
The slide shows a UI screenshot with a zoomed-in callout highlighting the 'Literature' tab and evidence table.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
15
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
16
The chart uses a segmented bar approach to compare established industry players against BenevolentAI's projected output.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
17
The slide uses a hub-and-spoke style diagram to show how a central platform feeds into four different commercialization strategies.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
18
The chart uses a timeline-like structure to show drug development stages from Target ID to Phase II.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a two-column layout to contrast the disease burden (left) with the proposed therapeutic solution (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
20
Includes specific caveats regarding study power and dosing duration.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
The slide uses a split-column layout to contrast the disease burden/market need (left) with the proposed solution/mechanism (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a process diagram to show the experimental workflow (biopsy to culture to measurement) followed by bar charts showing cytokine reduction.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
23
The slide uses a combination of a horizontal timeline and a three-column process breakdown.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
24
The chart shows a horizontal bar representation of drug development stages. Some programs are marked with AstraZeneca partnership logos and dates.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
25
The slide uses a split-layout with a summary of the partnership on the left and a timeline of expansion on the right.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
28
BenevolentAI | Investor Conference Presentation Deck | 29 slidesBenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
29
Neon-style text effect on a dark blue background.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Berkeley Lights | Investor Conference Presentation Deck | 26 slidesBerkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
02
Berkeley Lights | Investor Conference Presentation Deck | 26 slidesBerkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
03
The slide uses a stacked area chart to represent historical innovation waves and a vertical list of metrics to quantify the current gene/cell therapy market.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Current Reality (Pain)Loop · Aha Moment1 hit
04
The slide uses a process flow diagram to contrast the company's focus on 'Function' against the 'Sequence' and 'Edit' markets.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Current Reality (Pain)Loop · Aha Moment1 hit
05
The timeline uses a stylized wave graphic to connect years, with vertical callouts for specific events.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Current Reality (Pain)Loop · Golden Circle1 hit
06
The slide uses a minimalist design with a circular icon representing cellular/circuit technology.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Golden Circle1 hit
07
Berkeley Lights | Investor Conference Presentation Deck | 26 slidesBerkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Golden Circle1 hit
08
The slide uses a timeline-style process flow to represent strategic pillars.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Golden Circle1 hit